Skip to content

SCHEDULE 13G/AAccepted Feb 14, 2:20 PM ET

Lyell Immunopharma, Inc. SCHEDULE 13G/A

Foresite Capital Fund IV, L.P.

Accepted (ET)

2:20 PM

Feb 14, 2025

Filed

Feb 14, 2025

Documents

1

Size

23.1 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.